Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725895 | SCV000340318 | uncertain significance | not provided | 2016-03-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725895 | SCV000618383 | uncertain significance | not provided | 2017-08-14 | criteria provided, single submitter | clinical testing | The Q717E variant in the TRIOBP gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The XX variant is observed in 232/66734 (0.35%) alleles from individuals of non-Finnish European background in the ExAC dataset (Lek et al., 2016). The Q717E variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret Q717E as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000765638 | SCV000896967 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 28 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000725895 | SCV002459743 | benign | not provided | 2024-01-06 | criteria provided, single submitter | clinical testing |